ArticlePharmaceutics2026

Connecting the Dots Between Pharmacokinetics, Inflammatory Biomarkers, and Mucosal Healing in Patients on Infliximab with Inflammatory Bowel Disease.

Ana Homšek Ilić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.